drugset

drugset / Trial / NCT06301854

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

NCT06301854 ↗

Phase 3 Completed 472 enrolled Vigonvita Life Sciences

NaSingle-groupOpen-labelTreatment

Summary

This is a multicenter, open study to evaluate the long-term safety and efficacy of TPN171H in men with erectile dysfunction.

Timeline

Start: 2024-04-12
Primary completion: 2025-06-05
Completion: 2025-06-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TPN171H	Unknown	10 mg	—

Indications